The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorUniversity Health Network, Toronto
About this trial
The goal of this clinical trial is to test radiofrequency ablation (RFA) in thyroid cancers ≤2 cm in diameter. The main question it aims to answer is:
• What is the feasibility of RFA use for low-risk thyroid cancers (≤2 cm)?
Participants will undergo a set of pre-procedural scans of the target thyroid nodule and undergo the RFA procedure/intervention. Then, participants will partake in three follow-up appointments at 4 weeks, 6 months, and 12 months post-procedure as per standard of care.
Eligibility criteria
Qualifiers
Nodule less than or equal to 2cm in size
Their age is ≥18 years and ≤100 years
Able to provide written consent
Able to attend required follow-ups as per the protocol
Disqualifiers
Patients <18 years old
Pregnant women
Any concern for invasive or metastatic thyroid cancer
Previously treated for thyroid cancer
Trial design
Treatments tested in this trial
- Radiofrequency ablation
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov